共 16 条
[1]
[2]
[3]
[4]
Toll-like receptor 5 deficiency attenuates interstitial cardiac fibrosis and dysfunction induced by pressure overload by inhibiting inflammation and the endothelial–mesenchymal transition[J] Yuan Liu;Zhe-fu Hu;Hai-han Liao;Wei Liu;Juan Liu;Zhen-guo Ma;Qing-qing Wu;Man Xu;Ning Zhang;Yao Zhang;Zhou-yan Bian;Qi-zhu Tang BBA - Molecular Basis of Disease 2015,
[5]
Anti-toll like receptor 4 (TLR4) therapy diminishes cardiac remodeling regardless of changes in blood pressure in spontaneously hypertensive rats (SHR)[J] Cinthya Echem;Gisele Facholi Bomfim;Graziela Scalianti Ceravolo;Maria Aparecida Oliveira;Rosângela Aparecida Santos-Eichler;Luiz Roberto Bechara;Mariana Matera Veras;Paulo Hilário Nascimento Saldiva;Julio Cesar Ferreira;Eliana Hiromi Akamine;Zuleica Bruno Fortes;Ana Paula Dantas;Maria Helena Catelli de Carvalho International Journal of Cardiol
[6]
Structural Biology of the Toll-Like Receptor Family[J] Jin Young Kang;Jie-Oh Lee Annual Review of Biochemistry 2011,
[7]
Immunological aspect of cardiac remodeling: T lymphocyte subsets in inflammation-mediated cardiac fibrosis[J] Liu Wei Experimental and Molecular Pathology 2010,
[8]
Myocardial Ischemia/Reperfusion Injury Is Mediated by Leukocytic Toll-Like Receptor-2 and Reduced by Systemic Administration of a Novel Anti–Toll-Like Receptor-2 Antibody[J] Circulation 2010,
[9]
High Glucose Induces Toll-Like Receptor Expression in Human Monocytes: Mechanism of Activation[J] Dasu; Mohan R;Devaraj; Sridevi;Zhao; Ling;Hwang; Daniel H;Jialal; Ishwarlal Diabetes 2008,
[10]
Role of T Lymphocytes in Hypertension-Induced Cardiac Extracellular Matrix Remodeling[J] Qianli Yu;Katherine Horak;Douglas F. Larson Hypertension 2006,

